ABG Innovation Capital Partners III’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-36,747
| Closed | -$736K | – | 2 |
|
|
2025
Q1 | $736K | Hold |
36,747
| – | – | 91.94% | 1 |
|
|
2024
Q4 | $979K | Hold |
36,747
| – | – | 90.45% | 1 |
|
|
2024
Q3 | $1.05M | Hold |
36,747
| – | – | 93.29% | 1 |
|
|
2024
Q2 | $800K | Buy |
36,747
+3,121
| +9% | +$67.9K | 93.07% | 1 |
|
|
2024
Q1 | $745K | Sell |
33,626
-3,121
| -8% | -$69.1K | 89.54% | 1 |
|
|
2023
Q4 | $793K | Buy |
36,747
+3,121
| +9% | +$67.4K | 88.14% | 1 |
|
|
2023
Q3 | $568K | Hold |
33,626
| – | – | 77.21% | 1 |
|
|
2023
Q2 | $461K | Hold |
33,626
| – | – | 63% | 1 |
|
|
2023
Q1 | $764K | Hold |
33,626
| – | – | 70.27% | 1 |
|
|
2022
Q4 | $792K | Hold |
33,626
| – | – | 60.43% | 1 |
|
|
2022
Q3 | $877K | Hold |
33,626
| – | – | 59.46% | 1 |
|
|
2022
Q2 | $738K | Buy |
+33,626
| New | +$738K | 54.91% | 1 |
|